Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
3001 Red Lion Road, Philadelphia, PA, 19114, US
PCI is a leading global CDMO, providing integrated end-to-end drug development, manufacturing and packaging solutions to increase product speed to market and opportunities for commercial success. PCI brings proven experience with over 90 product launches each year and over five decades in the delivery of supply chain healthcare services.
Expansions at sites in both the United States and Europe are crucial to PCI’s vision for the coming years.
Released By PCI Pharma Services
PCI’s Jeff Clement discusses key areas of investment and insight into recent sterile fill-finish and injectable packaging expansions.
Technological advancements, global market dynamics, and patient-centric approaches are all factors driving the transformation of the parenteral drug market.
Experts at PCI Pharma Services discuss trends and challenges associated with digital transformation in the pharmaceutical industry.
Tim Roberts, Chief Commercial Officer, PCI Pharma Services, discusses industry trends, growing business sectors, and key investments.
PCI Pharma Services’ Louise Carpenter outlines the vital role formulation development plays in the rapidly growing field of oncology outsourcing.
Shawn Cain, senior VP of development and manufacturing at PCI Pharma Services, discusses pharma and biopharma outsourcing trends.
Mitigate potential delays while awaiting IND approval with a Pre-IND strategy.
The following six strategies can be used to find balance; nevertheless, they all require the support of a trusted clinical packager.
Guiding a compound quickly through clinical trials requires a balanced approach between resources, speed, quality and cost. PCI’s SpeedtoStudyTM service accelerates drug development timelines, and moves your drug candidates forward. DOWNLOAD TO LEARN MORE>>>>
Water Cooler Chat
Investigational Medicinal Products
PHILADELPHIA – August 24, 2020 – PCI Pharma Services (“PCI“), a leading pharmaceutical and biopharmaceutical global supply chain solutions provider, and portfolio company of Partners Group, announced today the signing of a definitive agreement for the acquisition of majority stake in the company by Kohlberg & Company, LLC (“Kohlberg“). Kohlberg is a leading private equity […]
PCI provides full development and manufacturing services for both investigational and commercial products, including highly potent molecules requiring specialist handling. With over 35 years of experience in processing potent and non-potent drug products, PCI provides a true partnership and consultative approach from pre-clinical formulation development and API characterization through to full commercial launch. […]
PCI Broadens Global Clinical Supply-Chain Service Offerings Into Mainland Europe
With over 35 years’ experience in the development and manufacturing of potent and non-potent drug products, plus more than 50 years’ commercial packaging expertise combined with over 50 successful product launches each year, we are a trusted partner and industry leader in the commercialization of new products. Our clients come to us seeking solutions […]
PCI is committed to supporting clients at every stage of the clinical cycle, delivering best-in-class services efficiently and effectively. Our clients come to us seeking solutions to often complex and unique opportunities due to our reputation in offering unmatched flexibility, a client-centric experience and consultative approach. We deliver a seamless clinical service including pharmaceutical […]
PCI Pharma Services Announces Completion of Biotech Center of Excellence in Philadelphia and Expansions to Biotech Capabilities in Europe
In this technical brief, you will learn how improved patient outcomes have been made possible by innovation in therapeutic coatings for medical devices.
Will serve as a central hub for Barentz’s Pharma activities in North America.
By: Charlie Sternberg
Lind brings over 25 years of biopharmaceutical experience to the role.
Dr. Max Lauwiner, CEO of Valsynthese, discusses the role of small-sized CDMOs in securing Pharma innovation pipelines.
Released By Valsynthese
The two companies have collaborated on other fronts since 2021.
By: Patrick Lavery
Designed to deliver precise performance in a compact footprint to support clinical, pharma research and research labs.
By: Kristin Brooks
Huang brings 25+ years of leadership experience across the pharmaceutical and CDMO sectors.
Inaugurates new production lines for both standard and sterile ready-to-use (RTU) glass vials.
Why pragmatic, risk-based quality systems may offer a smarter path for sponsors and CDMOs than compliance theater and zero-defect thinking.
By: Lisa Cozza, Scott Myers
Successfully tech-transferred and manufactured first commercial-scale GMP batches of Renaissance Pharma’s lead candidate, Daretabart.
Delivers faster changeovers, higher OEE, and improved operational efficiency for pharmaceutical manufacturers and CDMO environments.
As pharma companies rethink global supply networks, CPHI Americas puts regional resilience, contract manufacturing, and long-term outsourcing partnerships at the center of the conversation.
By: Sara Griffin
Aims to boost clinical supply and commercialization readiness for Ratio’s lead radiopharmaceutical therapy.
Addressing quality and regulatory requirements for pharmaceutical applications.
Released By gChem
Besremi is a treatment for polycythemia vera for which PharmaEssentia is seeking a label expansion to include essential thrombocythemia.
Strategic partnership aims to strengthen Ac-225 production and improve radiopharmaceutical supply reliability.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
